Trade Setup Buy Target $9.27 Sell Target $10.93 Trailing Stop 20% Greenlight Capital Re, Ltd., through its subsidiaries, operates as a property and casualty reinsurer worldwide. The company offers various property reinsurance products and services, including automobile physical damage; personal lines, such as homeowners’ insurance; and commercial lines. It also provides casualty reinsurance products and […]
Read MoreWhile the rest of the market has been pushing to a new set of all-time highs – as of the end of last week, the S&P 500 was up nearly 19% year-to-date – the energy sector has been struggling lately. As measured by the S&P 500 Energy Sector SPDR ETF (XLE), the sector is down […]
Read MoreThis tech stock has been surging higher, and one technician says it has got more upside ahead.
Read MoreIf you pay attention to the stock market, you inevitably become familiar with some of the personalities that take up space on market media to talk about it. On CNBC, for example, Jim Cramer is an ever-present commentator. Not only does he host his own “Mad Money” show in the afternoons on the network, you’ll […]
Read MoreKeep these 6 robust stocks on your radar – they can weather the coming storm.
Read MoreThe billionaire investor just issued a warning, and says this is the asset to buy now to prepare for what’s coming.
Read MoreThese 5 consumer stocks are the ones to keep an eye on now.
Read MoreBuy Target $1.22 Sell Target $1.41 Trailing Stop 20% BioTime, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing therapies for the treatment of degenerative diseases in the United States and internationally. The company’s lead product candidates include OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa multicenter trial for […]
Read MoreWall Street sees double-digit upside ahead for these 6 stocks. Here’s why.
Read MoreAs the earnings season heats up, Morgan Stanley is betting on these 4 stocks.
Read MoreNo. 5: Union Pacific Corp. (UNP) Shares of Union Pacific — which operates the largest railroad system in the U.S. and is one of the world’s largest transportation companies in general — surged 5.9% during Thursday’s session from the previous close of $164.55 to $174.25. With that settlement, UNP stock is now up more than […]
Read MoreTrade Setup Buy Target $3.49 Sell Target $4.16 Trailing Stop 20% Conformis, Inc., a medical technology company, develops, manufactures, and sells joint replacement implants. The company offers customized knee replacement products, including iTotal CR, a cruciate-retaining product; iTotal PS, a posterior cruciate ligament substituting product; iDuo, a customized bicompartmental knee replacement system; and iUni, a […]
Read MoreOne of the most underwhelming sectors in this market this year has been Healthcare. As measured by the S&P 500 Healthcare Sector SPDR ETF (XLV), the sector is up just about 6.5% year to date, while the broad market hit a new all-time high earlier and is up a little over 19% since the beginning […]
Read MoreShares of Netflix Inc. (NFLX) endured massive double-digit losses after the closing bell Wednesday following the Q2 earnings release. The streaming giant reported some of its worst user numbers in years, leading investors to rake the stock over the coals and drag it toward the lowest levels of 2019. While most public companies traditionally rely […]
Read MoreTrade Setup Buy Target $1.52 Sell Target $1.68 Trailing Stop 20% vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, discovers and develops orally administered small molecule drug candidates to fill unmet medical needs. The company is developing Azeliragon, an orally administered, small molecule antagonist targeting the receptor for advanced glycation endproducts, which is in Phase II/III […]
Read More